2019
Capital Markets Day
2018
IR conference call on Odyssey Outcomes
Sanofi and Regeneron conference call for the financial community on the results of the ODYSSEY OUTCOMES study.
IR call on the acquisition of Ablynx
Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Ablynx.
IR call on the acquisition of Bioverativ Inc.
Sanofi hosted a conference call & webcast for the financial community to present the acquisition of Bioverativ Inc.
2017
Sustaining Innovation Analyst Day
Sanofi organized an analyst meeting to discuss Sanofi’s R&D strategy and development pipeline.
Dupixent® FDA approval call
Sanofi and Regeneron hosted a conference call following the approval of Dupixent® in the U.S.
2016
IR thematic call on dupilumab
Sanofi and Regeneron hosted a conference call focusing on dupilumab.
IR thematic call – Building global leadership in Consumer Healthcare
Sanofi organized a conference call following the signing of contracts with Boehringer Ingelheim.
2015
IR thematic call on sarilumab
Sanofi and Regeneron hosted a conference call on sarilumab.
Meet Sanofi Management
Sanofi organized a Meet Management Seminar focusing on its strategic roadmap 2020.
IR thematic call on Praluent® FDA approval
Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.
IR thematic call on Diabetes
Sanofi and Regeneron hosted a conference call on the Praluent® FDA approval in the U.S.
2014
IR thematic seminar on New Medicines
Sanofi hosted an IR Thematic Seminar on New Medicines.
IR thematic call with Serge Weinberg
Sanofi held a conference call with Serge Weinberg for the financial community.
IR thematic call on alirocumab
Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the European Society of Cardiology Congress in Barcelona.
IR thematic call on Diabetes
Sanofi hosted a Thematic Conference Call on Diabetes in connection with the American Diabetes Association's Scientific Sessions.
IR thematic call on alirocumab
Sanofi and Regeneron hosted an IR Thematic Conference Call focusing on alirocumab during the American College of Cardiology Annual Meeting.